BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 598422)

  • 1. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
    Wing LM; Reid JL; Davies DS; Neill EA; Tippett P; Dollery CT
    Eur J Clin Pharmacol; 1977 Dec; 12(6):463-9. PubMed ID: 598422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
    Dollery CT; Reid JL
    Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.
    Davies DS; Wing AM; Reid JL; Neill DM; Tippett P; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):593-601. PubMed ID: 870272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The central hypotensive effect of clonidine. Studies in tetraplegic subjects.
    Reid JL; Wing LM; Mathias CJ; Frankel HL; Neill E
    Clin Pharmacol Ther; 1977 Apr; 21(4):375-81. PubMed ID: 321174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and clinical effects of three brands of clonidine: the relationship between plasma level and effect.
    Kanto J; Allonen H; Hiltunen R; Marvola M; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):118-21. PubMed ID: 7068284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.
    Frisk-Holmberg M; Edlund PO; Paalzow L
    Br J Clin Pharmacol; 1978 Sep; 6(3):227-32. PubMed ID: 687501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology and pharmacokinetics of clonidine.
    Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
    Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of tolerance to hypotensive effects of clonidine in spontaneously hypertensive rats.
    Naruse T; Ishii R; Tagawa T
    Jpn J Pharmacol; 1995 Apr; 67(4):407-410. PubMed ID: 7650877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
    Findlay D; Lawrence JR
    Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent resistance to hypotensive effect of clonidine.
    Wing LM; Reid JL; Davies DS; Dargie HJ; Dollery CT
    Br Med J; 1977 Jan; 1(6054):136-8. PubMed ID: 832037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man.
    Frisk-Holmberg M; Paalzow L; Wibell L
    Eur J Clin Pharmacol; 1984; 26(3):309-13. PubMed ID: 6734692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects.
    Anavekar SN; Jarrott B; Toscano M; Louis WJ
    Eur J Clin Pharmacol; 1982; 23(1):1-5. PubMed ID: 7128667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and side-effects of clonidine.
    Keränen A; Nykänen S; Taskinen J
    Eur J Clin Pharmacol; 1978 May; 13(2):97-101. PubMed ID: 658114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedation and plasma concentration of clonidine hydrochloride for pre-anesthetic medication in pediatric surgery.
    Sumiya K; Homma M; Watanabe M; Baba Y; Inomata S; Kihara S; Toyooka H; Kohda Y
    Biol Pharm Bull; 2003 Apr; 26(4):421-3. PubMed ID: 12673018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sliding intravenous dose schedule for clonidine in hypertensive patients.
    Velasco M; Gallardo E; Plaja J; Guevara J
    Clin Pharmacol Ther; 1976 Jul; 20(1):31-5. PubMed ID: 776490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical pharmacology of clonidine: relationship between plasma concentration and pharmacological effect in animals and man.
    Reid JL; Barber ND; Davies DS
    Arch Int Pharmacodyn Ther; 1980; Suppl():11-6. PubMed ID: 7416873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma clonidine levels in hypertension.
    Velasquez MT; Rho J; Maronde RF; Barr J
    Clin Pharmacol Ther; 1983 Sep; 34(3):341-6. PubMed ID: 6883910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.